載入...
Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
Renin–angiotensin–aldosterone system (RAAS) inhibitors are the key medications for patients with heart failure and chronic kidney disease. Multiple randomized controlled trials have demonstrated their benefits in an outpatient setting for the treatment of chronic heart failure. Additional advantages...
Na minha lista:
| 發表在: | Drugs Context |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioExcel Publishing Ltd
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7673621/ https://ncbi.nlm.nih.gov/pubmed/33240389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-7-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|